NCT03932370

Brief Summary

Management of nephrolithiasis is evolving rapidly, and various minimally-invasive urological procedures are currently available for treating patients with renal stones, including extracorporeal shockwave lithotripsy (ESWL), flexible ureteroscopy (f-URS) and miniaturised percutaneous nephrolithotomy (mini-PCNL). Despite being the only truly-non-invasive, outpatient procedure, stone-free rates (SFRs) of ESWL are lower than both mini-PCNL and f-URS. Furthermore, ESWL has several limitations, such as pregnancy; uncorrected coagulopathy;aortic aneurism; severe obesity; large stone burdens (\>2cm); stones with high densities (\>970/1000 Hounsfield units); ESWL-resistant stone compositions; lower calyceal stones with unfavourable anatomical criteria; and stones in calyceal diverticula; Morbidities of the conventional PCNL are significantly minimised by using less access diameters in PCNL while providing comparable SFRs. Additionally, Mini and Micro PCNL result in shorter hospital stay and higher tubeless rates compared to conventional PCNL. Flexible ureteroscopy has been increasingly used as a primary modality for treatment of renal stones with significantly lower complication rates than PCNL and mini-PCNL in terms of less bleeding and transfusion rates, shorter hospital stay and less postoperative pain. Additionally, f-URS is the only treatment modality of nephrolithiasis that can be safely and effectively used in patients with bleeding tendency, as well as pregnant women; moreover, its outcomes are not affected by obesity. Nevertheless, its poor durability and high costs remain major limitations for f-URS, especially in developing countries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
118

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 30, 2019

Completed
27 days until next milestone

Study Start

First participant enrolled

May 27, 2019

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 27, 2021

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

2.2 years

First QC Date

April 27, 2019

Last Update Submit

September 24, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • initial stone clearance

    Number of participants who has been totally cleared of stones as measured by KUB and ultrasound

    24 hours after the operation

  • final stone clearance

    Number of participants who has been totally cleared of stones as measured by non-contrast CT

    90 days after the operation

Secondary Outcomes (3)

  • Operative time

    Within 24 hours

  • Hospital stay

    Within a week from the operation

  • Haemoglobin drop

    within 24 hours

Study Arms (2)

f-URS

Procedure: Flexible ureteroscopy

mini-PCNL

Procedure: mini-Percutaneus nephrolithotomy

Interventions

The procedure will be performed in an endourology room where a radiolucent operative table together with a C-arm, a video-camera unit and a Laser device are available. Irrigation fluids include normal saline and/or sterile water.

Also known as: RIRS, f.URS, Retrograde Intrarenal Surgery
f-URS

The procedure is done in the prone position under fluoroscopy guidance with a semi-rigid 12Fr. Nephroscope

Also known as: Mini-perc, Mini-PCNL, m.PCNL
mini-PCNL

Eligibility Criteria

Age16 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

no specific criteria

You may qualify if:

  • Age above than 15 years
  • Renal stone(s) with total burden of 2 cm or less
  • Signature on written, informed consents with the details of this study requirements.
  • Inappropriateness or failure of ESWL (examples of ESWL inappropriateness: patient preference; distal obstruction; contraindications of ESWL)

You may not qualify if:

  • Uncorrectable bleeding diathesis
  • Current pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut Urology and Nephrology Hospital

Asyut, Asyut Governorate, 71515, Egypt

Location

MeSH Terms

Conditions

Nephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer of urology

Study Record Dates

First Submitted

April 27, 2019

First Posted

April 30, 2019

Study Start

May 27, 2019

Primary Completion

July 30, 2021

Study Completion

December 27, 2021

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations